We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

By LabMedica International staff writers
Posted on 06 Aug 2025

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. More...

However, IMS is hindered by relatively low spatial resolution and a lack of cellular morphological detail—both of which are crucial for accurately interpreting molecular profiles within the structural context of tissue. Conventional workflows also rely on labor-intensive chemical staining and complex image registration, which consume time and compromise tissue integrity. Now, a novel diffusion-based virtual staining approach can transform low-resolution IMS data into high-resolution histological images, improving the clarity of tissue structure without sacrificing the original sample.

The artificial intelligence (AI)-based technique developed by an international team of researchers from the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), Vanderbilt University (Nashville, TN, USA) and Delft University of Technology (TU Delft, Delft, Netherlands) uses a diffusion-based generative model to virtually stain label-free IMS images. This model digitally produces images that closely resemble traditional histochemical staining—particularly Periodic Acid-Schiff (PAS) staining, which highlights polysaccharides, glycoproteins, and mucins—despite the original IMS data having pixel sizes nearly ten times larger than those of optical microscopy. By optimizing the noise sampling process during AI inference, the researchers enhanced the reliability and consistency of the virtual staining. The method allows the digital transformation of IMS data into high-resolution brightfield microscopy images, eliminating the need for chemical staining and preserving tissue samples for further molecular analysis.

The research team tested the solution in blind evaluations on human kidney tissues, where the virtually stained images successfully enabled pathologists to identify critical renal structures and disease features with accuracy comparable to conventional stained images. The results, published in Nature Communications, show that the technique significantly improves the interpretability of IMS data and holds potential for widespread clinical and research applications. By virtually introducing microscopic-level histological detail, the method supports IMS-driven molecular histology while streamlining workflows. The researchers anticipate that their AI-driven approach will open new possibilities in spatial biology and clinical diagnostics and plan to expand its use across other tissue types and staining modalities.

“This diffusion-based approach dramatically enhances the interpretability of mass spectrometry images. It virtually introduces microscopic-level histological detail, bridging the gap between molecular specificity and cellular morphology, all without chemically staining the tissue,” said Professor Aydogan Ozcan, corresponding author at UCLA.

Related Links:
UCLA 
Vanderbilt University
TU Delft


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.